Nantahala Capital Management’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Hold
3,376,484
0.2% 96
2025
Q4
$6.01M Hold
3,376,484
0.2% 96
2025
Q3
$8.14M Buy
3,376,484
+1,058,467
+46% +$2.57M 0.28% 78
2025
Q2
$5.26M Hold
2,318,017
0.21% 90
2025
Q1
$6.24M Buy
2,318,017
+643,452
+38% +$1.82M 0.25% 60
2024
Q4
$4.4M Sell
1,674,565
-535,028
-24% -$1.44M 0.19% 85
2024
Q3
$5.92M Buy
2,209,593
+182,993
+9% +$499K 0.3% 64
2024
Q2
$5.06M Sell
2,026,600
-39,856
-2% -$93.4K 0.3% 61
2024
Q1
$4.9M Hold
2,066,456
0.28% 64
2023
Q4
$5.81M Buy
2,066,456
+298,406
+17% +$859K 0.35% 56
2023
Q3
$5.78M Sell
1,768,050
-92,355
-5% -$295K 0.49% 47
2023
Q2
$4.67M Buy
+1,860,405
New +$2.96M 0.45% 50

Other funds holding NSPR

Nantahala Capital Management's NSPR Position: Q1 2026 in Review

Nantahala Capital Management held its InspireMD (NSPR) position steady in Q1 2026 at 3,376,484 shares worth $5.5M. The position accounts for 0.2% of the portfolio, ranked #96.

Nantahala Capital Management first reported a position in NSPR in Q2 2023 and has held it in 12 quarters since. The position peaked at $8.14M in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Nantahala Capital Management held 3,376,484 shares of InspireMD worth $5.5M as of Q1 2026.
  • Nantahala Capital Management left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up 0.2% of Nantahala Capital Management's portfolio in Q1 2026, its #96 holding.
  • Nantahala Capital Management first reported a position in InspireMD in Q2 2023 and has held it in 12 quarters since.
  • Nantahala Capital Management's InspireMD position peaked at $8.14M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.